Category: Medicines and Healthcare Products Regulatory Agency – MHRA
Assistive technology: definition and safe use
MHRA guidance updated to reflect the MDR – Clinical investigations of medical devices – Biological safety assessment
Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2018 to 2019
MHRA launches consultation on how to best engage patients and the public
New information about upcoming MDR and IVDR regulations added to the page – Medical devices: guidance for manufacturers on vigilance
Recommendations from the independent Expert Advisory Group on the use of Paclitaxel Drug-Coated Balloons (DCBs) and Drug-Eluting Stents (DESs) to the MHRA
Virtual manufacturing of medical devices.
Escopo da BSI para o MDR – Regulation (EU) 2017/745 on medical devices http://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=notification.pdf&dir_id=34&ntf_id=288798
MHRA response to EU exit no-deal legislative proposals consultation
After loosing the CE Mark and the ANSM recall – MHRA statement on Allergan
